Tobi podhaler 28 MG inhale cap UD 56S
Ended Awarded Last action
- Contract number
- SPE2DR26F21CQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,975
Award facts
- Contract value 100% obligated
- $59,975.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $59,975.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Tobi Podhaler 28 mg inhale capsules in unit dose packages (56 count). This is a non-set-aside competitive award with performance at the awardee's facility in Conshohocken, Pennsylvania, and an ultimate completion date of January 23, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
This delivery order supports the federal government's pharmaceutical procurement needs within the Defense Health Agency and broader military medical supply chain. Tobi Podhaler is a tobramycin inhalation powder used in respiratory and cystic fibrosis treatment, reflecting the comprehensive range of specialty medications that Cencora supplies under its DLA contract. The firm fixed-price structure and rapid completion timeline demonstrate the efficiency of the IDC vehicle in fulfilling urgent medical supply requirements for military healthcare systems. As a non-set-aside award, the contract was competitively awarded, underscoring Cencora's established capability to meet federal procurement standards through open competition.
Quick answers
Who was awarded contract SPE2DR26F21CQ?
SPE2DR26F21CQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F21CQ worth?
The government has obligated $59,975 on SPE2DR26F21CQ.
Is contract SPE2DR26F21CQ an order under another contract?
Yes. SPE2DR26F21CQ is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21CQ competed?
The extent of competition for SPE2DR26F21CQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award